Natco's partner Mylan Inc files ANDA for generic Copaxone
Drug firm Natco Pharma on Saturday said its marketing partner in America, Mylan Inc has filed an ANDA for generic Copaxone used in treatment of multiple sclerosis and expects 180 days of marketing exclusivity.
Aug 30, 2014, 20:13 PM IST